Welcome to the Modulim Booth
TAKE SOME TIME TO HOVER AROUND
The Modulim Booth is interactive with
various hover points built into the booth!
Explore the booth by using your mouse to hover over all the different elements in the booth and learn why this vascular imaging technology could be the next best thing to add to your practice!
Modulim
Modulim is a pioneer in subsurface optical imaging powered by spatial frequency domain imaging (SFDI), an advanced optical imaging technique invented by founder and CTO David Cuccia, Ph.D., and his colleagues at UC Irvine’s Beckman Laser Institute in California.
SFDI deciphers the reflection, absorbance, and scattering of light to more accurately measure key indicators of subsurface tissue integrity.
Modulim’s Clarifi® Imaging System is the first non-contact, noninvasive microvascular assessment tool that uses a proprietary optical imaging technique — spatial frequency domain imaging (SFDI) — to provide insight into the delivery and extraction of oxygen to tissue. This information can help clinicians identify patients who are at risk for vascular complications and pinpoint specific areas of potential compromised circulation before the presence of visible symptoms (e.g., ulceration).
CLICK PLAY BUTTON TO WATCH VIDEO
Modulim’s Clarifi® Imaging System is the first non-contact, noninvasive microvascular assessment tool that uses a proprietary optical imaging technique — spatial frequency domain imaging (SFDI) — to provide insight into the delivery and extraction of oxygen to tissue. This information can help clinicians identify patients who are at risk for vascular complications and pinpoint specific areas of potential compromised circulation before the presence of visible symptoms (e.g., ulceration).
CLICK PLAY BUTTON TO WATCH VIDEO
Clarifi Imaging System
The Clarifi® Imaging System is the first non-contact, noninvasive microvascular assessment tool that uses a proprietary optical imaging technique — spatial frequency domain imaging (SFDI) — to provide insight into the delivery and extraction of oxygen to tissue.
This information can help clinicians identify patients who are at risk for vascular complications and pinpoint specific areas of potential compromised circulation before the presence of visible symptoms (e.g., ulceration).
Your Booth Rep
Gary Marsten
Gary Marston joined Modulim in 2017 and is currently the Vice President of Sales and Marketing. He is responsible for the commercialization of our industry leading technology for measuring microvascular dysfunction at the point of care – Clarifi Imaging System. Gary has over 25 years of experience in medical device industry working with patients, providers and payers.
Use the chat feature at the bottom of your screen to start a virtual conversation with Gary now!